Papp, K., M. Lebwohl, A. Gottlieb, M. Sebastian, R. Langley, Y. Okubo, M. Wang, C. Cioffi, F. Staelens, and K. Reich. “Bimekizumab for the Treatment of Moderate to Severe Plaque Psoriasis With Scalp, Nail and Palmoplantar Involvement Through 52 Weeks: Post-Hoc Analysis from the BE VIVID Phase 3 Trial”. SKIN The Journal of Cutaneous Medicine, vol. 5, no. 1, Jan. 2021, p. s18, doi:10.25251/skin.5.supp.18.